Boston, Massachusetts 02115


Purpose:

The purpose of this research study is to assess outcomes of treatment for early prostate cancer. Current treatments for early (non-metastatic) cancer may cause long-term impairments in the patients quality of life. In this study we will compare the outcomes of patients treated with two alternative brachytherapy (seed implants) techniques using a series of questionnaires.


Study summary:

Participants will be asked to complete a questionnaire about their health prior to treatment, at 1, 3 and 12 months after treatment and then once a year 4 more times.


Criteria:

Inclusion Criteria: - Pathological diagnosis of an adenocarcinoma of the prostate - 18 years of age or older - Prior choice of either standard brachytherapy or MRIGPB as primary treatment Exclusion Criteria: - Prior primary therapy (surgery or external beam radiation) for prostate cancer - Current hormone ablation therapy


NCT ID:

NCT00681694


Primary Contact:

Principal Investigator
James Talcott, MD, SM
Massachusetts General Hospital

James Talcott, MD, SM
Phone: 617-724-5451
Email: jtalcott@partners.org


Backup Contact:

Email: aerodrigues@partners.org
Anita Rodrigues


Location Contact:

Boston, Massachusetts 02115
United States



There is no listed contact information for this specific location.

Site Status: Recruiting


Data Source: ClinicalTrials.gov

Date Processed: January 21, 2020

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

If you would like to be contacted by the clinical trial representative please fill out the form below.